Transgenomic


TRANSGENOMIC is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Our offering includes systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine.
	WAVE^®Systems and Consumables
	SURVEYOR^® Mutation Detection Products
	Cytogenetics Automated Systems
	Molecular Laboratory
	Pharmacogenomic Services

TRANSGENOMIC technologies are highlighted in more than 1,600 peer-reviewed journal articles.

What's New

Meetings/Seminars
Listen Webcast Alert Reminder - Transgenomic Inc. Reports First Quarter 2008 Results Apr 24 - May 21
Investor Presentation Investor Presentation 4/30/2008
Inaugural Pediatric Neurosciences Conference May 15 - 17

Key Publications

Abstract - The mitochondrial DNA control region shows genetically correlated levels of heteroplasmy in leukocytes of centenarians and their offspring.

Abstract - Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia

Abstract - Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism

More News
May 7 Press Releases Press Release - Transgenomic, Inc. Reports First Quarter 2008 Results
May 7 Press Releases Press Release - Reminder - Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
Apr 30 Press Releases Press Release - Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines

Contact Webmaster

Send Page To Colleague

Printable Page

Change Country United States

the power of discovery™